Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amarin Corporation plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
AMRN
Nasdaq
2836
www.amarincorp.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amarin Corporation plc
RHHBY's Lunsumio Combo Meets Goal in 2L Follicular Lymphoma Study
- Sep 17th, 2026 8:48 am
RCKT Aligns With FDA on Completing Phase II Study in Danon Disease
- Sep 16th, 2026 8:56 am
Why Is Tango Therapeutics (TNGX) Down 6.2% Since Last Earnings Report?
- Sep 10th, 2026 9:30 am
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
- Sep 9th, 2026 1:54 pm
Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
- Aug 31st, 2026 6:15 am
New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
- Aug 28th, 2026 6:15 am
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
- Aug 26th, 2026 9:13 am
Amarin to Present New REDUCE-IT and EPA Analyses at ESC Congress 2026
- Aug 24th, 2026 8:10 am
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
- Aug 24th, 2026 6:15 am
European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading
- Aug 12th, 2026 9:11 am
TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses
- Aug 12th, 2026 8:46 am
Amarin (AMRN) Q2 2026 Earnings Call Transcript
- Aug 7th, 2026 7:28 pm
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
- Jul 31st, 2026 7:40 am
BHC Q2 Earnings Beat Estimates on Salix and Solta Growth, '26 View Raised
- Jul 30th, 2026 10:33 am
Amarin Corp PLC (AMRN) Q2 2026 Earnings Call Highlights: Strategic Growth Amidst Revenue Challenges
- Jul 29th, 2026 1:03 pm
Amarin's Q2 Earnings Beat Estimates, Revenues Fall Short
- Jul 29th, 2026 10:17 am
Amarin Reports Second-Quarter Results as Partnered International Strategy Gains Momentum
- Jul 29th, 2026 8:42 am
Amarin Q2 Earnings Call Highlights
- Jul 29th, 2026 7:03 am
Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
- Jul 29th, 2026 5:00 am
Scroll